Pancreatic Cancer Therapy
Research reports on pancreatic cancer therapy from University of Occupational and Environmental Health provide new insights
Published in Obesity and Diabetes Week, February 9th, 2009
A new study, 'Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience,' is now available. According to recent research published in the journal Radiation Medicine, "The aim of this study was to evaluate the efficacy and toxicity of concurrent chemoradiotherapy (CRT) with gemcitabine plus regional hyperthermia (HT) for locally advanced pancreatic carcinoma (LAPC). A total of 29 patients with LAPC treated with concurrent CRT using gemcitabine were retrospectively analyzed."
"Radiotherapy was administered with a median total dose of 61.2 Gy. Of the 29 patients, 20 (69%) also underwent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Weight loss in overweight and obese women reduces urinary incontinence - Wiley-Blackwell
Economic status affects obesity rates in Mexican-American and white women - Wiley-Blackwell
Fatty liver disease medication may have no effect - Wiley-Blackwell
Study examines burden of diabetes on US hospitals - Yale University
Aspirin can prevent liver damage that afflicts millions, Yale study finds - Depression
Avoiding Secondhand Smoke During Pregnancy: New Study of African-American Women Shows Social Factors Impact Success - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
